Morgan Stanley expects US healthcare stocks to rebound strongly, citing sector catalysts, major investments by Eli Lilly and AstraZeneca, tariff protection, AI adoption, and a 30% valuation discount to the S&P 500.
#YonhapInfomax #MorganStanley #HealthcareStocks #SP500 #EliLilly #AstraZeneca #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88849
Morgan Stanley Says US Healthcare Sector Poised for Strong Rebound

Morgan Stanley expects US healthcare stocks to rebound strongly, citing sector catalysts, major investments by Eli Lilly and AstraZeneca, tariff protection, AI adoption, and a 30% valuation discount to the S&P 500.

Yonhap Infomax